Thioridazine Hydrochloride manufacturers & suppliers

Thioridazine Hydrochloride

Form: Oral tablets

Strength: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg

Reference Brands: Mellaril(US)

Category: Antipsychotropic Drugs

Thioridazine Hydrochloride is a typical antipsychotic medication used for the treatment of schizophrenia and other psychotic disorders. It belongs to the phenothiazine class and works by altering the actions of chemicals in the brain. Available in oral tablet form with strengths including 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, Thioridazine is known under the brand Mellaril in the US, though its use has been limited due to cardiac risks. While largely discontinued in the US and many EU countries, it may still be found in niche markets. Ideal for pharma B2B platforms serving specialized psychiatric care.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details
Zuclopenthixol Short-Acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details
Zuclopenthixol Tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.